Results 221 to 230 of about 77,670 (298)

Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer

open access: yesClinical and Translational Medicine, Volume 15, Issue 4, April 2025.
1. In theory, CAR‐engineering therapy can achieve therapeutic effects by targeting cells expressing specific antigens and thereby eliminating or regulating disease‐related cell subpopulations. 2. Although CAR‐engineering therapy is currently only approved for the treatment of cancer, it has also shown potential in non‐tumour diseases. 3.
Lvying Wu, Lingfeng Zhu, Jin Chen
wiley   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Genetically edited human placental organoids cast new light on the role of ACE2. [PDF]

open access: yesCell Death Dis
Arthurs AL   +12 more
europepmc   +1 more source

Unlocking New Pharma/Nutraceutical Frontiers With Neuroprotective Properties of Three Hypericum Species: A Study Combination With In Vitro and In Silico Methodologies

open access: yesFood Science &Nutrition, Volume 13, Issue 4, April 2025.
This study investigates the phytochemical composition and biopharmacological potential of the extracts from three Hypericum species (H. scabrum, H. lysimachioides, and H. uniglandulosum) from Turkey. The results indicate significant therapeutic potential for these extracts, supporting their development as natural agents against oxidative stress ...
Muammer Bahsi   +12 more
wiley   +1 more source

Neuropilin‐1 as a Neuroinflammatory Entry Factor for SARS‐CoV‐2 Is Attenuated in Vaccinated COVID‐19 Patients: A Case–Control Study

open access: yesHealth Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aim COVID‐19 is caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) as a pandemic infectious disease. So far, it has been known that this virus uses several receptors to enter the host cell, one of which is neuropilin‐1 (NRP1).
Faezeh Hosseini   +6 more
wiley   +1 more source

PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2. [PDF]

open access: yesJ Virol
Ma R   +14 more
europepmc   +1 more source

Significance of Neurological Manifestations and Their Association With Clinical Outcomes in Hospitalized COVID‐19 Patients in Bandar Abbas, Iran: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background Neurological manifestations are increasingly recognized in COVID‐19 patients, yet their prevalence and clinical significance remain understudied. This study aimed to determine the incidence and significance of neurological symptoms and their associations with demographic, clinical, and laboratory parameters in hospitalized COVID‐19 ...
Ahmadagha Negahi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy